Rankings
▼
Calendar
CRIS Q2 2024 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena
CRIS
Curis, Inc.
$15M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
+15.9% YoY
Gross Profit
$3M
99.5% margin
Operating Income
-$13M
-491.4% margin
Net Income
-$12M
-463.6% margin
EPS (Diluted)
$-2.03
QoQ Revenue Growth
+22.1%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$50M
Total Liabilities
$51M
Stockholders' Equity
-$694,000
Cash & Equivalents
$10M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$2M
+15.9%
Gross Profit
$3M
$2M
+19.4%
Operating Income
-$13M
-$12M
-3.1%
Net Income
-$12M
-$12M
+1.3%
← FY 2024
All Quarters
Q3 2024 →